This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by ÖSTENSON, C.-G. Articles by EFENDIC, S. Search for Related Content PubMed PubMed Citation Articles by ÖSTENSON, C.-G. Articles by EFENDIC, S.

₂-Adrenoceptor Blockade Does Not Enhance Glucose-Induced Insulin Release in Normal Subjects or Patients With Noninsulin-Dependent Diabetes^*

Departments of Endocrinology (C.-G.O., S.E.) and Anaesthesiobgy (J.P.), Karolinska Hospital Stockholm, Sweden
Reckitt & Colman (J.C.D.) Kingstone-upon-Hull, United Kingdom

Address all correspondence and requests for reprints to: Dr. C.-G. Östenson, Department of Endocrinology, Karolinska Hospital, S-10401 Stockholm, Sweden.

Studies with phentolamine, an -adrenergic antagonist, in normal subjects and diabetic patients have indicated that insulin secretion may be inhibited by tonic -adrenergic stimulation of pancreatic B-cells. We evaluated, with the use of the highly selective ₂-adrenoceptor antagonist idazoxan, the role of ₂-adrenergic receptors in the regulation of glucoseinduced insulin secretion. A glucose infusion test (GIT) was performed after the administration of idazoxan or placebo in normal men (n = 15) and men with noninsulin-dependent diabetes mellitus (n = 6). The normal men were divided into two groups on the basis of high (n = 8) and low (n = 7) insulin responses to prior GITs. The blood glucose and plasma insulin and C-peptide responses to the GIT were similar after idazoxan (40 mg, orally) or placebo treatment in all three groups, although the responses differed among the groups. In the diabetic group iv administration of idazoxan 20 min before the GIT did not alter the insulin response to the GIT. We conclude that ₂-adrenergic blockade does not affect glucose-induced insulin secretion in normal men, nor does it improve the impaired first phase of insulin secretion in low insulin responders and noninsulin-dependent diabetes mellitus patients. Phentolamine probably stimulates insulin secretion by a mechanism not involving ₂-adrenergic receptors directly.

^* This work was supported by grants from the Swedish Medical Research Council (19X-00034), the Swedish Diabetes Association, the Nordic Insulin Foundation, the Magnus Bergvall Foundation, the Swedish Medical Society, and funds of the Karolinska Institute.

Received February 8, 1988.

This article has been cited by other articles:

				K. Hatlapatka, A. Wienbergen, C. Kuhne, A. Jorns, M. Willenborg, and I. Rustenbeck Selective Enhancement of Nutrient-Induced Insulin Secretion by ATP-Sensitive K+ Channel-Blocking Imidazolines J. Pharmacol. Exp. Ther., December 1, 2009; 331(3): 1033 - 1041. [Abstract] [Full Text] [PDF]

				J.-C. Henquin Pathways in Beta-Cell Stimulus-Secretion Coupling as Targets for Therapeutic Insulin Secretagogues Diabetes, December 1, 2004; 53(suppl_3): S48 - S58. [Abstract] [Full Text] [PDF]

				C. Bleck, A. Wienbergen, and I. Rustenbeck Glucose Dependence of Imidazoline-Induced Insulin Secretion: Different Characteristics of Two ATP-Sensitive K+ Channel-Blocking Compounds Diabetes, December 1, 2004; 53(suppl_3): S135 - S139. [Abstract] [Full Text] [PDF]

				B. Davani, N. Portwood, G. Bryzgalova, M. K. Reimer, T. Heiden, C.-G. Ostenson, S. Okret, B. Ahren, S. Efendic, and A. Khan Aged Transgenic Mice With Increased Glucocorticoid Sensitivity in Pancreatic {beta}-Cells Develop Diabetes Diabetes, February 1, 2004; 53(90001): S51 - 59. [Abstract] [Full Text]

				S. Efendic, A. M. Efanov, P.-O. Berggren, and S. V. Zaitsev Two Generations of Insulinotropic Imidazoline Compounds Diabetes, December 1, 2002; 51(90003): S448 - 454. [Abstract] [Full Text] [PDF]

				T. Leon-Quinto, C. Magnan, and B. Portha Altered Activity of the Autonomous Nervous System as a Determinant of the Impaired {beta}-Cell Secretory Response after Protein-Energy Restriction in the Rat Endocrinology, August 1, 1998; 139(8): 3382 - 3389. [Abstract] [Full Text] [PDF]

				A. Natali, A. Gastaldelli, A. Q. Galvan, A. M. Sironi, D. Ciociaro, G. Sanna, P. Rosenzweig, and E. Ferrannini Effects of acute alpha 2-blockade on insulin action and secretion in humans Am J Physiol Endocrinol Metab, January 1, 1998; 274(1): E57 - E64. [Abstract] [Full Text] [PDF]